Dutch registry of coronary function tests
Part of Heart & circulation clinical trials.
This study collects information from people who are already scheduled for a coronary function test, to learn more about heart vessel health. By joining, you help researchers understand patterns and improve care for others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being referred for a coronary function test (CFT) to check how your heart's blood vessels work.
- You are willing to provide written consent to join the registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people having tests to check how well the blood vessels in the heart work. It helps doctors learn more about these tests and improve care for future patients.
This study is collecting information about how well the tiny blood vessels in the heart work in people with chest pain. It helps doctors learn more about microcirculation problems and may lead to better treatments.
This trial looks at how to assess small blood-vessel (microvascular) problems in people who had a heart attack but whose main heart arteries are not blocked. It may help doctors better find what’s driving symptoms and choose the right tests and treatments.
This study is looking at people who have chest pain or shortness of breath but whose heart arteries look fairly open on an angiogram. It aims to understand why they have symptoms and how to improve care. You may qualify if you're having a coronary angiogram and it shows no major blockages.
This trial tests a drug that blocks certain receptors to see if it reduces chest pain caused by coronary artery spasm. If you have frequent angina despite current treatments, this study may offer a new option.
This trial is a registry that collects information from people undergoing an invasive heart artery test (coronary angiography). It helps researchers understand heart disease and outcomes in real-world patients.
Hear when a new Coronary Microvascular Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.